Company: PBH
Filing Date: 2025-06-27
Form Type: DEF 14A
Source: 0001295947-25-000021
Chunk: 34

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-06-27
Form: DEF 14A
Chunk 34
---
 In considering the results of this advisory vote on executive compensation, the Compensation and Talent Management Committee concluded that the compensation paid to our named executive officers and the Company’s overall compensation program enjoy strong stockholder support. We also regularly meet with our largest stockholders and solicit feedback on a wide range of topics. 2024 SAY ON PAY APPROVAL

Compensation Governance Highlights We endeavor to maintain good governance standards including with respect to the oversight of our executive compensation policies and practices, as evidenced by the following practices of our Compensation and Talent Management Committee:

| The Committee is composed solely of independent directors.                                                                                                                                 | The Committee conducts an annual review of ourcompensation-related risk profile to ensure thatcompensation-related risks are not reasonably likelyto have a material adverse effect on the Company. |
| The Committee’s independent compensation consultant,CAP, is retained directly by the Compensation and TalentManagement Committee and performs no other consultingor other services for us. | The Committee regularly reviews succession andtalent management.                                                                                                                                    |

| 46 |     | 2025 Proxy Statement | Prestige Consumer Healthcare Inc. |

Executive Compensation

Executive Compensation Best Practices

| No Evergreen Provision.The Company’s 2020 Long-Term Incentive Plan(“2020 LTIP”) does not contain an “evergreen”feature pursuant to which the shares authorizedfor issuance under the 2020 LTIP can beautomatically replenished.                                                                                                                                                                                                                                                                                                                                |
| No Repricing of Stock Options.Without the prior approval of the Company’sstockholders, outstanding stock options cannot berepriced, directly or indirectly, nor may stock optionsbe cancelled in exchanged for stock options with anexercise price that is less than the exercise price ofthe original stock options. In addition, the Companymay not, without the prior approval of stockholders,repurchase an option for value from a participant ifthe current market value of the underlying stockis lower than the exercise price per share ofthe option. |
| Clawback Policy.All awards (and/or any amount received with respectto such awards) under the Annual Incentive Plan andthe 2020 LTIP are subject to reduction, cancellation,forfeiture or recoupment to the extent necessary tocomply with applicable law, stock exchange listingrequirements, and the recoupment policy ofthe Company.                                                                                                                                                                                                                         |
| Minimum Vesting Requirements.Awards granted under the 2020 LTIP will be subjectto a minimum vesting period of one year except for5% of the pool that is available to grant withshort